Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease
Stephen G Holt, Edward R Smith
Nephrology Dialysis Transplantation | OXFORD UNIV PRESS | Published : 2016
Thanks to A/Prof Eric Hanssen (Head, Advanced Microscopy Unit, Bio21, University of Melbourne) for technical assistance with the EM analyses presented in Figure 1. Funding has been obtained from the National Health and Medical Research Council (NHMRC) Australia, Jacquot Foundation and Royal Melbourne Hospital. The authors have also between them received research grants, honoraria or lecture fees from Amgen, Baxter, Gilead, Sanofi and Vifor Pharma. E.R.S. owns stock in Calciscon.